window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Technology and platforms

  • Biotech,Digital Health,Technology and platforms

    Research finds scientists view ELNs as ‘glorified filing cabinets’, driving duplication and shadow AI use

    A new survey by Sapio Sciences has found widespread frustration [...]

    January 30, 2026
  • Clinical Trials,Digital Health,Patient Centricity,Real world evidence,Technology and platforms

    Kayentis and Ametris partner on integrated eCOA and wearable adherence platform

    Kayentis and Ametris have announced a strategic partnership to integrate [...]

    January 30, 2026
  • Diagnostics,Infectious Diseases,Medical devices,Technology and platforms

    En Carta Diagnostics receives FDA breakthrough device designation for Lyme disease test

    En Carta Diagnostics has received FDA Breakthrough Device Designation for [...]

    January 30, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Movers & Shakers,Regulatory Affairs,Technology and platforms

    Spore.Bio appoints Michael Miller as VP of scientific and regulatory affairs

    Spore.Bio has appointed Michael Miller as vp of scientific and [...]

    January 30, 2026
  • Clinical Development,Digital Health,Patient Centricity,Technology and platforms

    Beauregard Health System unifies post-appointment medication messaging with Artera and DrFirst integration

    Beauregard Health System has integrated Artera’s patient communication platform and [...]

    January 27, 2026
  • Biotech,Drug Development,Partnerships & Funding,Rare Diseases,Technology and platforms

    Mendra launches with $82 million Series A to develop rare disease therapies

    Mendra, Inc. has launched with the closing of an $82 [...]

    January 23, 2026
  • Artificial Intelligence,Biotech,Clinical Trials,Diagnostics,Oncology,Precision medicine,Research & Development,Technology and platforms

    SpotitEarly announces strategic partnership with Fox Chase Cancer Center to advance early cancer detection

    SpotitEarly has formed a strategic partnership with Fox Chase Cancer [...]

    January 21, 2026
  • Clinical Trials,Data Management,Digital Health,Technology and platforms

    Zeroport raises $10 million seed to address remote access security risks in pharma and clinical trials

    Zeroport has raised $10 million in seed funding to expand [...]

    January 20, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Sustainability,Technology and platforms

    SGD Pharma leads pharma packaging innovation and decarbonisation at Pharmapack Europe 2026

    SGD Pharma, a global producer of pharmaceutical glass primary packaging, [...]

    January 20, 2026
  • Artificial Intelligence,Clinical Development,Clinical Trials,Data Management,Digital Health,Pharmaceuticals and therapeutics,Technology and platforms

    From outputs to outcomes: Saama’s Derek Lawrence on why clinical data management must change

    Clinical data management is under pressure to evolve as trials [...]

    January 20, 2026
Previous456Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
  • Chemify founder publishes three papers on programmable chemistry and automated drug discovery
    Categories: Artificial Intelligence, Drug discovery, Research & Development, Technology and platforms
  • European liver experts highlight rising MASLD burden at EASL symposium in Budapest
    Categories: Clinical studies, Gastroenterology, Healthcare leadership, Liver disease, Metabolic Diseases
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top